Dr. Ajna Hukic Kilalic

 

Curriculum Vitae

Studium

1997 – 2003

Studium der Humanmedizin, Universität Sarajevo, Bosnien und Herzegowina

Beruflicher Werdegang

1996 – 1997

Übersetzerin
Public Affairs Office American Forces und American Embassy Bosnia and Herzegowina

05/2003 – 05/2004

AiP, Universitätsklinikum in Sarajevo

11/2004 – 3/2005

Praktischer Arzt
Medizinische Versorgungszentren in Bosnien und Herzegowina

03/2005 – 12/2010

Weiterbildungsassistentin
Institut für Pathologie der Medizinischen Universität, Uniklinikum Sarajewo, Bosnien und Herzegowina

01/2010

Facharztprüfung für Pathologische Anatomie
Bosnien und Herzegowina

11/2011

Magisterarbeit „Das Verhältnis der Expression von der Cyclooxigenase-2 (COX-2) und der Neoangiogenese bei Magenkrebs“

01/2010 – 03/2016

Fachärztin
Pathologisches Institut der Medizinischen Universität Sarajevo, Bosnien und Herzegowina

2016

Ärztin
Institut für Pathologie-Molekularpathologie, Deggendorf

11/2017 – 09/2019

Assistenzärztin
Zentrum für Pathologie Kempten-Allgäu
Medizinisches Versorgungszentrum am Klinikum Kempten

04/2018

Deutsche
Approbation

10/2019 – 01/2020

Assistenzärztin
Robert-Bosch-Krankenhaus Stuttgart, Abteilung für Pathologie

2020-2022

Assistenzärztin
Institut für Pathologie Kaufbeuren Ravensburg

2022

Anerkennung als Facharzt für Pathologie

Mitgliedschaften

  • Deutsche Abteilung der internationalen Akademie für Pathologie (IAP)
  • Bundesverband Deutscher Pathologen (BDP)
  • Gesellschaft der Pathologie und Zytologie der Föderation von Bosnien und Herzegowina

Publikationen

[1] Dorić M, Kuskunović-Vlahovljak S, Lazović Salčin E, Babić M, Radović S, Hukić A. Intratumoural lymphatic vascular density (LVD) correlate with progesterone receptor expression in breast carcinoma. Folia Medica. 2014;49(1):5-13.

[2] Dorić M, Kuskunović-Vlahovljak S, Radović S, Hukić A, Babić M, Lazović Salčin E. Lymphangiogenesis in breast carcinoma is present but insufficient for metastatic spread. Journal of Health Sciences. 2014;4(1):4-11.

[3] Hukić A, Radović S, Kuskunović-Vlahovljak S, Dorić M, Babić M, Lazović Salčin E. Relation between cyclooxygenase-2 expression and neoangiogenesis in gastric cancer. Healthmed. 2013;7(7):2195-2200.

[4] Hukić A,, Radović S, Kuskunović S, Dorić M, Babić M, Lazović Salčin E.Relation between cyclooxygenase-2 expression and neoangiogenesis in gastric cancer. HealthMED. 2013;7(7):2195-2200.

[5] Radović S. , Hukić A,, Dorić M, Kuskunović S, Babić M. The immunohistochemical expression of COX-2 and NM23 in gastric adenocarcinoma: correlation with clinicopathological variables. HealthMED. 2013;7(6):1854-1863.

[6] Radović S, Dorić M, Hukić A,, Babić M, Kuskunović S, Spahović N. Immunohistochemical expression and significance of NM23 suppressor protein in primary gastric adenocarcinoma. Bosn J Basic Med Sci. 2013;13(2):72-77.

[7] Lazović Salčin E., Radović S,, Babić M,, Dorić M,, Kuskunović S,, Tomić I ,Hukić A,,HER2 protein expression in invasive gastric carcinoma. Folia Medica. 2013;48(1):19-25.

[8] Radović S, Dorić M, Zujo H, Hukić A, Kuskunović S, Babić M, Tomić I. Interdigitating dendritic cell sarcoma of the liver and lung: a case report with morphohological and immunohistochemical features of tumor. Bosnian Journal of basic medical 2012;12(3):203-6.

[9] Hukić A,, Radović S, Kuskunović S, Dorić M, Babić M, Tomić I.,Lazović Salčin E. Influence of cyclooxygenase-2 on neoangiogenesis in gastric cancer. Folia Medica. 2012;47(2):38.

[10] Lazović Salčin E., Dorić M, Radović S, Babić M, Kuskunović S, Hukić A,, Tomić I., Expression of HER2 protein in gastric cancer: immunochistochemistry study. Folia Medica. 2012;47(2):39.

[11] Kuskunović S., Radović S., Dorić M., Hukić A., Babić M., Tomić I., Selak I. Immunochistochemical expression of tissue inhibitor of metalloproteinase-1 TIMP-1) in invasive breast carcinoma. Bosnian Journal of basic medical sciences. 2009; (2): 125-130.

[12] Dorić M., Radović S., Babić M., Hukić A., Kuskunović S., Tomić I. Lymphangiogenesis in breast carcinoma is unsuccessful. Abstract book, Second Interconference Breast Cancer Meeting (IBCM-2), Sarajevo, 23-25. April 2009, BiH.

[13] Dorić M., Radović S., Kuskunović S., Hukić A., Babić M., Tomić I., Selak I. Dermal squamomelanocytic tumor: neoplasm of uncertain biological potential. Bosnian Journal of basic medical sciences. 2008; 2: 152-155.

[14] Dorić M., Radović S., Babić M., Kuskunović S., Hukić A., Tomić I., Selak I. Lymphangigenesis in invasive breast carcinoma. Acta.Med. Sal. 2008;37 (Suppl. 1): 99.

[15] Dorić M., Radović S., Hukić A., Kuskunović S., Babić M., Tomić I., Selak I. Promjene u timusnom epitelu štakora nakon izlaganja zearalenonu, Veterinaria, 2008; 57(1-2):1-11.

[16] Kuskunović S., Radović S., Dorić M., Babić M., Selak I., Hukić A., Tomić I. Prognostic value of protein P27KIP1 in invasive ductal breast cancer. Acta Med. Sal. 2008; 37 (Suppl. 1): 86.

[17] Hukić A. Telemedicine and Telepathology in Bosnia and Herzegovina: Present perspectives and Obstacles. Acta Informatica Medica 2007 (4); 237-239

[18] Dorić M., Radović S., Kuskunović S., Babić M., Hukić A., Tomić I., Selak I. Dermal squamomelanocytic tumor: a case report neoplasm of uncertain biological potential. Prvi kongres dermatovenerologa BIH, Sarajevo 23-26 maj 2007; Abstract book 0-40, pp 50

[19] Babić M., Radović S., Hukić A., Kuskunović S., Dorić M., Tomić I., Selak I. Immunohistochemical analysis of proliferative nodule in congenital melanocitic naevus (CMN). Prvi kongres dermatovenerologa BIH, Sarajevo 23-26 maj 2007; Abstract book, P-52, pp 97

[20] Radović,S.,Babić,M.,Dorić,M., Hukić A., Kuskunović S., Hadžismajlović A., Serdarević F. Non-small cell lung carcinoma: cyclin D1, bcl-2, Ki-67 and HER-2 proteins expression in resected tumors. Bosnian Journal of basic medical sciences, 2007;7 (3): 205-211.

[21] Dorić M., Radović,S.,Babić,M.,Hukić, A.,Kuskunović, S., Tomić I.,Selak I. Testicular metastasis of gastriontestinal stromal tumor of the jejunum. Bosnian Journal of basic medical sciences. 2007; 2: 176-179.

[22] Dorić M., Radović S., Babić,M., Kuskunović S., Tomić I., Hukić A., Selak I. Giant cell fibroblastoma in 4-year-old boy. Case report and rewiew of literature.Med.Arh. 60 (6): 389-390. 2006.